1. Summary Information         

 

 

Country

India

Company Name

MEDREICH LIMITED

Principal Name 1

Mr. Chandanmal Pukhraj Bothra

Status

Satisfactory

Principal Name 2

Mr. Keith De Souza Frances

 

 

Registration #

08-002383

Street Address

Medreich House No 12/8, Saraswathi Ammal Street, Maruthi Seva Nagar, Bangalore-560033, Karnataka, India

Established Date

16.08.1973

SIC Code

--

Telephone#

91-80-25493334

Business Style 1

Manufacturer

Fax #

91-80-25474741

Business Style 2

--

Homepage

http://www.medreich.com

Product Name 1

Ampicillin

# of employees

462 (approximately)

Product Name 2

Amoxicillin

Paid up capital

Rs.1407,183,338/-

Product Name 3

Cloxacillin

Shareholders

Foreign holdings – 73%

Bodies corporate – 27%

Banking

State Bank of Mysore

Public Limited Corp.

NO

Business Period

39 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

Ba (49)

Related Company

Relation

Country

Company Name

CEO

Holding Company

United Kingdom

Medreich Holdings (UK) Limited

--

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2011

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

1,385,570,000

Current Liabilities

635,621,000

Inventories

725,422,000

Long-term Liabilities

743,036,000

Fixed Assets

870,676,000

Other Liabilities

163,982,000

Deferred Assets

0,000

Total Liabilities

1,542,639,000

Invest& other Assets

1,846,170,000

Retained Earnings

1,878,016,000

 

 

Net Worth

3,285,199,000

Total Assets

4,827,838,000

Total Liab. & Equity

4,827,838,000

 Total Assets

(Previous Year)

4,278,473,000

 

 

P/L Statement as of

31.03.2011

(Unit: Indian Rs.)

Sales

3,317,448,000

Net Profit

391,151,000

Sales(Previous yr)

3,204,584,000

Net Profit(Prev.yr)

483,966,000

 

MIRA INFORM REPORT

 

 

Report Date :

21.08.2012

 

IDENTIFICATION DETAILS

 

Name :

MEDREICH LIMITED

 

 

Formerly Known As :

MEDREICH STERILAB LIMITED

 

 

Registered Office :

Medreich House No 12/8, Saraswathi Ammal Street, Maruthi Seva Nagar, Bangalore-560033, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

16.08.1973

 

 

Com. Reg. No.:

08-002383

 

 

Capital Investment / Paid-up Capital :

Rs.1407.183 Millions

 

 

CIN No.:

[Company Identification No.]

U24232KA1973PLC002383

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRS01934C

 

 

PAN No.:

[Permanent Account No.]

AABCM1458Q

 

 

Legal Form :

A closely held Public Limited Liability Company.

 

 

Line of Business :

Manufacturers of Pharmaceutical Formulations.

 

 

No. of Employees :

462 (approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (49)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 13000000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of Med Holdings (UK) Limited, United Kingdom. It is an established company having satisfactory track. There appears some dip in the profitability during 2011.

 

However, trade relations are reported as decent. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office / Corporate Office:

Medreich House No 12/8, Saraswathi Ammal Street, Maruthi Seva Nagar, Bangalore-560033, Karnataka, India

Tel. No.:

91-80-25493334 [10 Lines]

Fax No.:

91-80-25474741

E-Mail :

bnk@ho.medreich.com

query@ho.medreich.com

medreich@vsnl.com

cg@ho.medreich.com

info@ho.medreich.com

pi@ho.medreich.com

medreich@vsnl.com

venkatesh.y@medreich.com

Website :

http://www.medreich.com

Area :

1500 sq. ft.

Location :

Leased

 

 

Factory 1 :

Survey No. 4/3, Avalahalli, Off Kanakpura Road, Anjanapura Post, Bangalore, Karnataka, India

Tel. No.:

91-80-28436375 / 89

 

 

Factory 2 :

12th Mile, Old Madras Road, Virgo Nagar, Bangalore – 560049, Karnataka, India

Tel no.:

91-80-28472402 / 403

Area :

3500 sq. ft.

Location :

Owned

 

 

Factory 3 :

49 B, C and D, Bommasandra Industrial Area, Bangalore, Karnataka, India

Tel No.:

91-80-7831338 / 7831339

 

 

Factory 4 :

Plot No. 36, Bommasandra Industrial Area, Bangalore, Karnataka, India

Tel no.:

91-80-7831338 / 7835068

 

 

Factory 5 :

No.54/2, Boodhihal Village, Kasba Hobli, Nelamangala Taluk, Bangalore – 562120, Karnataka, India

Tel No.:

91-80-27730358 / 27730359

 

 

DIRECTORS

 

AS ON 30.09.2011

 

Name :

Mr. Chandanmal Pukhraj Bothra

Designation :

Managing Director

Address :

No. 14, 7th Cross SS, Jai Bharat Nagar, Bangalore – 560033, Karnataka, India

Date of Birth/Age :

20.07.1956

Date of Appointment :

01.06.1990

DIN No. :

00023108

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232KA1973PLC002383

MEDREICH LIMITED

Managing director

01/06/1990

01/06/1990

-

Active

NO

2

U45203KA2004PTC033457

OZONE PROPERTIES PRIVATE LIMITED

Director

26/02/2004

26/02/2004

-

Active

NO

3

U74210KA2004PTC035015

OZONE PROPEX PRIVATE LIMITED

Director

16/11/2004

16/11/2004

-

Active

NO

4

U70101TN2005PTC056894

OZONE PROJECTS PRIVATE LIMITED

Director

13/07/2005

13/07/2005

-

Active

NO

5

U67120KA2005PTC036869

NOKHA HOLDINGS PRIVATE LIMITED

Director

01/08/2005

01/08/2005

-

Active

NO

6

U65993KA2005PTC037256

NOKHA INVESTMENTS PRIVATE LIMITED

Director

16/09/2005

16/09/2005

-

Active

NO

7

U24230KA2004PTC050438

MEDREICH CEPHTECH PRIVATE LIMITED

Nominee director

20/07/2006

20/07/2006

-

Amalgamated

NO

8

U24232KA2007PLC042361

ADCOCK INGRAM LIMITED

Managing director

20/02/2009

03/04/2007

01/04/2010

Active

NO

9

U24230KA2008PLC046164

GENOVO DEVELOPMENT SERVICES LIMITED

Nominee director

26/06/2008

23/04/2008

-

Active

NO

10

U24230KA2008PLC062782

MEDREICH LIFE CARE LIMITED

Nominee director

13/06/2008

06/06/2008

-

Active

NO

 

 

Name :

Mr. Keith De Souza Frances

Designation :

Director

Address :

90, Wyatt Drive, Barness, London, SW138 AB, England

Date of Birth/Age :

01.07.1955

Date of Appointment :

14.09.1996

DIN No. :

00022680

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232KA1973PLC002383

MEDREICH LIMITED

Director

14/09/1996

14/09/1996

-

Active

NO

2

U24232KA2007PLC042361

ADCOCK INGRAM LIMITED

Nominee director

01/11/2007

01/11/2007

-

Active

NO

 

 

 

Name :

Mr. Rajeev Mehta

Designation :

Director

Address :

80, Wyatt Drive, Barnes, London, England – SW 138AB

Date of Birth/Age :

19.08.1951

Date of Appointment :

19.05.2004

DIN No. :

00023079

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232KA1973PLC002383

MEDREICH LIMITED

Director

19/05/2004

19/05/2004

-

Active

NO

2

U24230KA2008PLC046164

GENOVO DEVELOPMENT SERVICES LIMITED

Nominee director

26/06/2008

26/06/2008

-

Active

NO

3

U24230KA2008PLC062782

MEDREICH LIFE CARE LIMITED

Nominee director

29/03/2011

29/03/2011

-

Active

NO

 

 

 

Name :

Mr. Shrikant Madhukar Bhide

Designation :

Nominee director

Address :

31 03 Shireesh 187, Veer Savarkar Road Mahim (West), Mumbai – 400016, Maharashtra, India

Date of Birth/Age :

27.08.1951

Date of Appointment :

19.12.2011

DIN No. :

00259180

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U72900MH2006PTC163428

SAUWAHAN INFOTECH PRIVATE LIMITED

Director

14/09/2006

14/09/2006

-

Active

YES

2

U74140MH2006PTC163935

ARYSE BUSINESS SOLUTIONS PRIVATE LIMITED

Managing director

01/10/2006

01/10/2006

-

Active

NO

3

U64100MH1988PLC047228

FIRST FLIGHT COURIERS LIMITED

Additional director

15/02/2008

15/02/2008

-

Active

NO

4

U24232KA1973PLC002383

MEDREICH LIMITED

Nominee director

19/12/2011

19/12/2011

-

Active

NO

 

 

Name :

Mr. Paul Michael Barett

Designation :

Chairman

Address :

1, Leicester Close, Henley – On – Thames, Oxon, RG92DLD, London, England

Date of Birth/Age :

09.11.1945

Date of Appointment :

19.05.2004

DIN No. :

00023297

 

 

Name :

Mr. Seow Teng Peng

Designation :

Director

Address :

2 Avon Road, Singapore – 439780

Date of Birth/Age :

05.05.1945

Date of Appointment :

14.10.2005

DIN No. :

01122683

 

 

Name :

Mr. Andrew Morris

Designation :

Director

Address :

Holy Tree House, Bovingdon, Greeen, Marlow Bucks-SL72JL, United Kingdom

Date of Birth/Age :

20.07.1962

Date of Appointment :

26.03.2009

DIN No. :

02705055

 

 

KEY EXECUTIVES

 

Name :

Mr. Venkatesh Yendapalli

Designation :

Company Secretary

Address :

101, Lakshmi Enclave, Behind Sambhram Institute of  Technology, Vidyaranyapura Post, Bangalore – 560097, Karnataka, India

Date of Birth/Age :

06.12.1966

Date of Appointment :

01.02.2009

Pan No. :

ABAPY3222B

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2011

 

Names of Equity Shareholders

No. of Equity Shares

Leela Kanwar

10

Vandana Bothra

10

Arun Kumar Chordia

10

Hemantha Kumar Bothra

10

Kushboo Bothra

10

Med Holdings Limited, United Kingdom, KT13AH 

21055093

Nokha Holdings Private Limited , Karnataka, India

7787450

V Sciences Investment Pte Limited, Singapore 

10000

Total

28852593

 

 

Name of Preference Shareholders

No. of Preference Shares

V Sciences Investment Pte Limited, Singapore 

14196160

 

 

AS ON 30.09.2011

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

73.00

Bodies corporate

27.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers of Pharmaceutical Formulations

 

 

Products :

Item Code Number

Product Description

30041003

Ampicillin

30041004

Amoxicillin

30041005

Cloxacillin

30031000

Potassium Clavulnate

 

PRODUCTION STATUS

 

(As on 31.03.2008)

Particulars

Unit

Installed Capacity*

Capsules

Millions / Annum

30770

Tablets

Millions / Annum

22500

Bottles

Millions / Annum

130

 

Particulars

Unit

Actual Production**

Capsules

Millions

10436

Tablets

Millions

11194

Liquids

Kilo Leters

1250

Vials

Millions

12215

 

Note:

 

* Excludes manufacturing capacity at sub-contractor locations.

** Includes quantities produced in factories of third parties under loan licenses.

 


 

GENERAL INFORMATION

 

No. of Employees :

462 (approximately)

 

 

Bankers :

·         State Bank of Mysore (Lead Bank), Corporate Accounts Branch, M.G. Road, Bangalore – 560001, Karnataka, India

·         Export Import Bank of India, Center one building, 21st Floor, World Trade Center, Complex, Cuff Parade, Mumbai - 400 005, Maharashtra, India

·         YES BANK LIMITED, Nehru Centre, 9th Floor, Dr. A. B. Road, Worli, Mumbai – 400018, Maharashtra, India

·         Canara Bank

·         Overseas Bank, M. G. Road, Bangalore – 560001, Karnataka,

·         Corporation Bank

·         Ing Vysya Bank Limited, 22, Ground Floor, Ing Vysya House, M. G. Road, Bangalore - 560001, Karnataka, India

 

 

Facilities :

Secured Loans

31.03.2011

(Rs. in millions )

31.03.2010

(Rs. in millions )

 

 

 

Working Capital Loans Banks Secured

743.036

339.059

Total

743.036

339.059

 

 

 

Banking Relations :

--

 

 

Financial Institution :

·         Housing Development Finance Corporation Limited

·         Karnataka State Financial Corporation

·         Karnataka State Industrial Investment and Development Corporation Limited

 

 

Auditors :

 

Name :

S. R. Batliboi and Associates

Chartered Accountants

Address :

U. B. City, Canberra Block, 12th and 13th Floor, No. 24, Vittal Mallya Road, Bangalore-560001, Karnataka, India

Tel. No.:

91-80-40275000

Fax No.:

91-80-22106000

Pan No.:

AABFS3421N

 

 

Subsidiaries :

·         Medreich Plc., United Kingdom

·         Medreich Cephtech Private Limited, India (ceased w.e.f 1.4.2009)

·         Medreich Lifecare Limited, India (formerly known as Medreich Saimirra Limited, India )

CIN No.: U24230KA2008PLC062782

·         Other enterprises under Common Control

·         Medreich South Africa Limited, South Africa

·         Medreich Far East Limited, Hong Kong

·         LDP - Laboratories Torlan, SA, Spain

·         Pharmazen Medicals Pte Limited, Singapore

·         Medreich Australia Pty Limited, Australia

·         SARL Medreich France, France

 

 

Joint Venture Companies:

·         Genovo Development Services Limited, India

CIN No.: U24230KA2008PLC046164

·         Adcock Ingram Limited, India *

CIN No.: U24232KA2007PLC042361

 

* Considered as Joint Venture as both share holders have equal control through representation on the Board of Directors.

 

 

Holding Company :

·         Medreich Holdings (UK) Limited, United Kingdom

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

44134259

Equity Shares

Rs.10/- Each

Rs.441.343 millions

14196160

Preference Shares

Rs.78.80/- Each

Rs.1118.657 millions

2

Preference Shares

Rs.1/- Each

Rs.0.000 millions

 

Total

 

Rs.1560.000 millions

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

28852593

Equity Shares

Rs.10/- Each

Rs.288.526 millions

14196160

Non cumulative participative convertible 1% Preference Shares

Rs.78.80/- Each

Rs.1118.657 millions

 

Total

 

Rs.1407.183 millions

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

1407.183

1407.183

1407.183

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1878.016

1802.973

1609.402

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

3285.199

3210.156

3016.585

LOAN FUNDS

 

 

 

1] Secured Loans

743.036

339.059

329.039

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

743.036

339.059

329.039

DEFERRED TAX LIABILITIES

104.434

95.916

88.416

 

 

 

 

TOTAL

4132.669

3645.131

3434.040

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

870.676

547.036

569.752

Capital work-in-progress

18.839

12.303

6.532

 

 

 

 

INVESTMENT

1827.331

1887.074

1802.074

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

725.422
534.854
562.405

 

Sundry Debtors

825.665
692.175
819.690

 

Cash & Bank Balances

44.200
28.370
33.063

 

Other Current Assets

26.213
51.885
19.460

 

Loans & Advances

489.492
524.776
421.162

Total Current Assets

2110.992
1832.060
1855.780

Less : CURRENT LIABILITIES & PROVISIONS

 
 
 

 

Sundry Creditors

600.590
486.800
605.142

 

Other Current Liabilities

35.031
61.121
92.580

 

Provisions

59.548
85.421
102.376

Total Current Liabilities

695.169
633.342
800.098

Net Current Assets

1415.823
1198.718
1055.682

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

4132.669

3645.131

3434.040

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

3317.448

3204.584

3011.875

 

 

Other Income

252.349

199.592

248.742

 

 

TOTAL                                     (A)

3569.797

3404.176

3260.617

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption materials changes inventories

2117.945

2032.486

2043.199

 

 

Employee related expenses

313.727

252.270

219.142

 

 

Administrative selling other expenses

513.291

419.752

398.488

 

 

TOTAL                                     (B)

2944.963

2704.508

2660.829

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

624.834

699.668

599.788

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

59.614

81.318

87.388

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

565.220

618.350

512.400

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

53.616

39.884

36.559

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

511.604

578.466

475.841

 

 

 

 

 

Less

TAX                                                                  (H)

120.453

94.500

133.942

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

391.151

483.966

341.899

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

1027.570

581.873

278.370

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend on Equity Shares

38.142

21.639

21.639

 

 

Proposed Dividend on Preference Shares

 

11.179

11.179

 

 

Tax on Proposed Dividend

 

5.451

5.578

 

 

Transfer to General Reserve

 

0.000

0.000

 

BALANCE CARRIED TO THE B/S

1380.579

1027.570

581.873

 

 

 

 

 

 

Earnings Per Share (Rs.)

9.09

11.24

11.40

 

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

10.96
14.22
10.49

 

 

 
 
 

Net Profit Margin

(PBT/Sales)

(%)

15.42
18.05
15.80

 

 

 
 
 

Return on Total Assets

(PBT/Total Assets}

(%)

17.16
24.31
19.62

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

0.16
0.18
0.16

 

 

 
 
 

Debt Equity Ratio

(Total Liability/Networth)

 

0.44
0.30
0.37

 

 

 
 
 

Current Ratio

(Current Asset/Current Liability)

 

3.04
2.89
2.32

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

No

31]

PAN of Proprietor/Partner/Director, if available

No

32]

Passport No of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

 

REVIEW OF THE COMPANY PERFORMANCE

 

During the year the Company has achieved net sales of Rs. 3021.819 Millions, registering a growth of 2.35% compared to previous year. Profit before interest, depreciation and taxes were Rs.329.205 Millions compared to Rs. 447.541 Millions previous year. After providing interest of Rs. 59.614 Millions (Rs. 81.318 Millions previous year) and depreciation of Rs.53.616 Millions (Rs. 39.883 Millions previous year) the profit before tax was Rs. 215.975 Millions as against the previous year’s profit of Rs. 326.340 Millions.

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24232KA1973PLC002383

Name of the company

MEDREICH LIMITED

Address of the registered office or of the principal place of  business in India of the company

Medreich House No 12/8, Saraswathi Ammal Street, Maruthi Seva Nagar, Bangalore-560033, Karnataka, India

E-mail id : venkatesh.y@medreich.com  

This form is for

Creation of charge

Type of charge

Movable Property 

Particular of charge holder

Ing Vysya Bank Limited, 22, Ground Floor, Ing Vysya House, M. G. Road, Bangalore - 560001, Karnataka, India

E-mail Id : giridharvvrn@ingvysyabank.com

Nature of instrument creating charge

Deed of General Hypothecation.

Date of instrument Creating the charge

25.04.2012

Amount secured by the charge

Rs.265.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

SBLC : commission 0.50% payable up-front. Libor (12 Months) + 300 BPS P.A payable monthly.

 

Terms of Repayment

SBLC : maximum up to 12 months.

 

Margin

SBLC : Nil

 

Extent and Operation of the charge

The charge is by way of Deed of Hypothecation executed/created by the company over its movable properties situated at Unit III at No.4/3, Avalahalli, Anjanapura Post, off kanakapura Main Road, Bangalore- 560062

Short particular of the property or asset(s) charged

The whole of the Company's movable fixed assets situated at Unit III at No.4/3, Avalahalli, Anjanapura Post, off kanakapura Main Road, Bangalore- 560062 both present and future.

 

 

FIXED ASSETS

 

·         Land

·         Factory Buildings

·         Office Buildings

·         Plant and Machinery

·         Electrical Equipments and Installations

·         Furniture and Fittings

·         Vehicles

·         Office Equipments

·         Computers

·         Software

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.70

UK Pound

1

Rs.87.55

Euro

1

Rs.68.85

 

INFORMATION DETAILS

 

Report Prepared by :

BSN

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

49

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.